B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure
Open Access
- 28 February 2005
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 149 (2), 363-369
- https://doi.org/10.1016/j.ahj.2004.05.051
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failureEuropean Heart Journal, 2002
- B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart FailureCirculation, 2002
- The B-type natriuretic peptide assay: a rapid test for heart failure.Cleveland Clinic Journal of Medicine, 2002
- B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspneaAnnals of Emergency Medicine, 2002
- BNP and congestive heart failureProgress in Cardiovascular Diseases, 2002
- Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomesJournal of Cardiac Failure, 2001
- Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationaleAmerican Heart Journal, 2001
- A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot studyJournal of Cardiac Failure, 2001
- High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failureJournal of the American College of Cardiology, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000